« Back
Home /
ERG Antibody (C-term) Blocking Peptide

ERG Antibody (C-term) Blocking Peptide

Item no.	ABC-BP6552b
Manufacturer	Abcepta
Amount	500 ug
Category	Oncology By Cell Type Hematology Leukemia Peptides & Proteins Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Rostad,K., APMIS 117 (8), 575-582 (2009)Yuan,L., Circ. Res. 104 (9), 1049-1057 (2009)Attard,G., Cancer Res. 69 (7), 2912-2918 (2009)
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Transcriptional regulator ERG,Transforming protein ERG,ERG
Similar products	ERG, Transcriptional regulator ERG, Transforming protein ERG
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence used to generate the antibody AP6552b was selected from the C-term region of human ERG. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background	ERG is a transcriptional regulator. The protein may participate in transcriptional regulation through the recruitment of SETDB1 histone methyltransferase and subsequent modification of local chromatin structure.
Gene Name	ERG
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP6552b-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer